Christina Kalemkeris, NP
Nurse Practitioner · Medford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 10 years
- Graduated 2016
Offices
1 location · Asante Physician Partners · 227 clinicians in this group
Looking this up.
Hospitals listed: Asante Rogue Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Christina Kalemkeris’s office at (541) 789-5710 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Asante Rogue Regional Medical CenterMedford, ORAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Asante Health System, which runs 3 hospitalsPatients rate it 3 of 5 · 75% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.221, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.252, Oct 2024 – Sep 2025
See every measure and the patient survey for Asante Rogue Regional Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 4 better, 6 the same, 0 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.221 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.252 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.69 (0 to 1.57) · 1,701 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.82 to 1.31) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 180.29 (142.35 to 218.23) · 179 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.2 · 238 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.3 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 317 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.5 · 410 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 278 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.7 · 390 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 4,099 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.31) · 7,066 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.05 to 0.42) · 7,782 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.47 (0.71 to 4.23) · 2,618 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.34 (1.1 to 3.59) · 1,195 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.27 (1.02 to 3.53) · 2,377 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 12 (7.91 to 16.09) · 1,111 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.39 (4.43 to 10.36) · 1,142 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.33 (0.94 to 3.73) · 510 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.5 (0 to 1.06) · 6,730 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.587 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.444 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.6 · 492 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 17.4 · 555 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 5.8 · 370 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -26.8 · 435 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 14 · 292 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 422 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.3 (4.9 to 8.1) · 573 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.4 (7.6 to 11.7) · 573 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 7.8 · 222 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (9.9 to 16.3) · 1,200 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 762 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,449 patients answered, 42% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 75% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 11% of their 247 Part D prescriptions in 2020.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2020 | 247 | 67 | 11% (28) | 11% | $9,076 |
| 2019 | 197 | 57 | 10% (19) | 15% | $8,816 |
| 2018 | 173 | 48 | 16% (27) | 10% | $4,430 |
| 2017 | 77 | 20 | None | 16% | $3,968 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2020: 7 drugs
| Clopidogrel | 20 | $394 | $20 |
| Atorvastatin | 15 | $189 | $13 |
| Oxycodone | 25 | $182 | $7 |
| Pantoprazole | 20 | $147 | $7 |
| Metoprolol | 23 | $145 | $6 |
| Gabapentin | 11 | $52 | $5 |
| Furosemide | 15 | $28 | $2 |
2019: 8 drugs
| Eliquis | 11 | $5,064 | $460 |
| Amiodarone | 14 | $137 | $10 |
| Pantoprazole | 21 | $121 | $6 |
| Oxycodone | 17 | $75 | $4 |
| Potassium Chloride | 13 | $75 | $6 |
| Gabapentin | 11 | $53 | $5 |
| Metoprolol | 13 | $52 | $4 |
| Furosemide | 13 | $26 | $2 |
2018: 4 drugs
| Oxycodone | 21 | $173 | $8 |
| Potassium Chloride | 15 | $169 | $11 |
| Metoprolol | 16 | $147 | $9 |
| Furosemide | 15 | $37 | $2 |
Money from drug and device companies
$662 in 2025
| 2025 | 3 | 6 | None | $662 |
| 2024 | 3 | 5 | None | $469 |
| 2023 | 1 | 1 | None | $105 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abiomed | None | $616 | 4 payments
|
| Ethicon US | Vistaseal | $37 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $10 | 1 payment
|
See all 6 published payments
| Abiomed | Travel · 2025-06-24 | None | $384 |
| Abiomed | Meals · 2025-06-24 | None | $22 |
| Abiomed | Meals · 2025-06-24 | None | $150 |
| Abiomed | Meals · 2025-06-24 | None | $60 |
| Ethicon US | Meals · 2025-06-05 | Vistaseal | $37 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-03-13 | Lifevest | $10 |
See earlier years (2024, 2023)
2024: $469
| Abiomed | Impella | $387 | 3 payments
|
| Edwards Lifesciences | Inspiris Resilia Aortic Valve | $54 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $28 | 1 payment
|
2023: $105
| Abiomed | Impella | $105 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.8 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1376093054
- Licence
- CA 95004794
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Nurse practitioner (363L00000X)
- Mailing address
- 300 Pasteur Dr, Palo Alto, CA, 94304
- NPI first listed
- 2016-10-06
- NPI last updated
- 2023-03-10
- NPI record certified
- 2023-03-10
This is when the NPI record was last certified, not a medical board exam.